Shanghai Kehua Bio-Engineering Co Ltd banner
S

Shanghai Kehua Bio-Engineering Co Ltd
SZSE:002022

Watchlist Manager
Shanghai Kehua Bio-Engineering Co Ltd
SZSE:002022
Watchlist
Price: 5.86 CNY 0.34% Market Closed
Market Cap: ¥3B

Shanghai Kehua Bio-Engineering Co Ltd
Investor Relations

Shanghai Kehua Bio-Engineering Co., Ltd. engages in the research, development, manufacture, and marketing business operation covering the whole industrial chain of vitro diagnostic device (IVD). The company is headquartered in Shanghai, Shanghai and currently employs 1,485 full-time employees. The company went IPO on 2004-07-21. The firm's products include in vitro diagnostic reagents, medical instruments and vacuum blood drawing supplies, among others. The firm operates its businesses in both domestic and overseas markets, with China as its main market.

Show more
Loading
002022
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Ming Li
Chairman & President
No Bio Available
Ms. Fang Luo C.P.A.
CFO & Financial Director
No Bio Available
Ms. Chao Chen
Senior Vice President
No Bio Available
Mr. Jiaming Liang
VP & Non-Independent Director
No Bio Available
Ms. Hongying Jin
VP, Board Secretary & Non Independent Director
No Bio Available
Mr. Shin Kang Hyuk
Vice President
No Bio Available

Contacts

Address
SHANGHAI
Shanghai
No.1189, Qinzhou North Road, Xuhui District
Contacts
+862164954576
www.skhb.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett